Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Hypha Labs (FUNI) Payables (2016 - 2025)

Hypha Labs filings provide 15 years of Payables readings, the most recent being $826942.0 for Q3 2025.

  • On a quarterly basis, Payables fell 28.99% to $826942.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $826942.0, a 28.99% decrease, with the full-year FY2025 number at $826942.0, down 28.99% from a year prior.
  • Payables hit $826942.0 in Q3 2025 for Hypha Labs, down from $1.6 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $1.6 million in Q4 2021 to a low of $397197.0 in Q2 2021.
  • Median Payables over the past 5 years was $913942.0 (2023), compared with a mean of $1.0 million.
  • Biggest five-year swings in Payables: skyrocketed 218.74% in 2021 and later tumbled 49.49% in 2023.
  • Hypha Labs' Payables stood at $1.6 million in 2021, then dropped by 17.02% to $1.4 million in 2022, then tumbled by 49.49% to $688185.0 in 2023, then soared by 77.59% to $1.2 million in 2024, then plummeted by 32.34% to $826942.0 in 2025.
  • The last three reported values for Payables were $826942.0 (Q3 2025), $1.6 million (Q2 2025), and $1.4 million (Q1 2025) per Business Quant data.